ConCallIQ
Go Pro
FR
FRACTALANALYTICS Other 15 Jan 2026

Fractal Analytics Ltd — Q3 FY26

Fractal delivered a strong Q3 FY26 with revenue of ₹854 crore, up 21% YoY, driven by 78% YoY growth in healthcare & life sciences and 26% in BFSI.

bullish high
Revenue ₹854 Cr +21%
EBITDA
PAT ₹100 Cr +10%
EBITDA Margin 17.8% +43bps
Duration 62 min

✓ Verified against BSE filing

2-Min Summary

Fractal delivered a strong Q3 FY26 with revenue of ₹854 crore, up 21% YoY, driven by 78% YoY growth in healthcare & life sciences and 26% in BFSI. Gross margin expanded 17 bps to 47.2%, while adjusted EBITDA margin improved 43 bps to 17.8%. PAT crossed ₹100 crore, up 10% YoY despite higher associate losses. Net revenue retention remained healthy at 114%, and must-win clients grew to 127. Management expects revenue growth to accelerate, aided by AI adoption and expansion of output-based contracts. Gross margin expansion and operating leverage should drive EBITDA margin improvement, though R&D investment (4.1% of revenue) will persist. Key risk: tariff uncertainty in CPG & retail, the largest vertical, could temper near-term growth.

Key Numbers

Must-win clients 127
+14 vs Mar'25

Must-win clients (MWCs) increased from 113 in March 2025 to 127, now contributing 83% of revenue.

Net revenue retention (NRR) 114%
Flat YoY

NRR of 114% indicates strong existing client expansion, contributing 14 points of revenue growth.

Healthcare & life sciences growth 78%
+78pp YoY

Healthcare & life sciences was the fastest-growing vertical, driven by strategic investments and AI solutions.

Revenue per billable headcount $85,000
+6% YoY (INR terms)

Revenue per billable headcount increased 6% in INR terms, reflecting productivity improvements and mix shift.

Management Guidance

G

Revenue growth to accelerate to historical ~30% CAGR

Management expects revenue growth to accelerate as AI adoption expands, targeting the historical 30% CAGR over 3-4 year periods.

revenue
G

Gross margin expansion to continue

Gross margins are expected to expand further driven by mix shift to output-based contracts and productivity improvements.

margins
G

Adjusted EBITDA margin to expand

Adjusted EBITDA margin is expected to expand as SG&A leverage improves and ESOP charges decline, while R&D investment continues.

margins
G

R&D investment to remain at ~4% of revenue or increase

Management plans to continue investing 4%+ of revenue in AI R&D, potentially increasing as gross margins expand.

ai_strategy

Key Risks

R

Tariff uncertainty in CPG & retail vertical

CPG & retail, Fractal's largest vertical (36% of revenue), grew only 14% YoY due to tariff-related headwinds and macroeconomic uncertainty, which could persist.

high · management_commentary
R

Client concentration and churn in TMT vertical

Two client-specific issues in telecom (Australia) and technology (US) caused a 6% YoY decline in APAC and dragged TMT vertical growth. Management noted these are exceptions but churn is ~1% of revenue.

medium · analyst_question
R

Increased losses from associate Qure.ai

Fractal's share of losses from Qure.ai increased to ₹19 crore (2.2% of revenue) from ₹3 crore last year, driven by US aid cuts. This weighed on PAT growth.

medium · management_commentary
R

Competition from frontier model providers

Analyst raised concern about potential competition from frontier AI model providers (e.g., OpenAI, Anthropic) entering enterprise workflow automation. Management argued they are complementary, but risk remains.

medium · analyst_question

Notable Quotes

We delivered a fantastic quarter, improving on nearly every metric.
Shriant Wamakani · Co-founder and Group CEO
Our strategic intent is to generate at least $1 billion of impact for each of our clients.
Shriant Wamakani · Co-founder and Group CEO
We expect our revenues will continue to accelerate at a faster pace.
Shriant Wamakani · Co-founder and Group CEO